Author

A. P. Solomon

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Organism:C. elegans· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

P. Neelakantan· 2 shared S. Vasudevan· 2 shared A. Prabhune· 1 shared A. Pudipeddi· 1 shared A. Stanley· 1 shared B. Palaniappan· 1 shared B. Thirunavukkarasu· 1 shared G. Ramage· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

P. Neelakantan

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Controlling Staphylococcus aureus by 2-phenol (2-MAMP) in a co-culture moderates the biofilm and virulence of Pseudomonas aeruginosa

G. T. Selvan, B. Thirunavukkarasu, N. N. Pravallika, S. Vasudevan, B. Palaniappan, A. P. Solomon

This study uses 2-MAMP to target Staphylococcus aureus in co-culture with Pseudomonas aeruginosa, reducing P. aeruginosa virulence factors and improving growth inhibition when combined with antibiotics.

bioRxiv · Jul 3, 2021 · PreprintMicrobiology

Design of a novel DNA Gyrase B inhibitor with a rhodanine scaffold: in silico and in vitro approaches

A. Pudipeddi, S. Vasudevan, K. Shanmugam, A. Stanley, V. P, P. Neelakantan, A. P. Solomon

The paper designs a novel DNA Gyrase B inhibitor using in silico and in vitro methods, identifying qsl-304 as a promising candidate with antibacterial activity against MRSA.

bioRxiv · Jan 24, 2021 · PreprintMicrobiology

Curcumin-Sophorolipid nano-conjugate inhibits Candida albicans filamentation and biofilm development

V. Rajasekar, P. Darne, A. Prabhune, R. Y. T. Kao, A. P. Solomon, G. Ramage, L. Samaranayake, P. Neelakantan

This study shows that a curcumin-sophorolipid nano-conjugate inhibits Candida albicans biofilm formation and filamentation at sub-inhibitory concentrations.

bioRxiv · Aug 12, 2020Microbiology